Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Halopyridinium cations as bifunctional donors of halogen and hydrogen bonds in salts with benzenesulfonic and p-toluenesulfonic acids

Matija Čulig ab, Vinko Nemec *a, Nikola Bregović a and Dominik Cinčić *a
aDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia. E-mail: vnemec@chem.pmf.hr; dominik@chem.pmf.hr
bR&D Pliva Croatia Ltd., member of Teva group, Prilaz baruna Filipovića 25, 10000 Zagreb, Croatia

Received 9th September 2025 , Accepted 23rd October 2025

First published on 23rd October 2025


Abstract

A selection of 10 mono- and dihalopyridines have been used as salt coformers for benzenesulfonic and p-toluenesulfonic acids. In most cases, the resultant halopyridinium cations are bifunctional donors of both charge-assisted hydrogen and halogen bonds to the sulfonate anions.


Strong intermolecular interactions like hydrogen (HBs) and halogen bonds (XBs) determine how molecular building units will connect in the crystal.1–4 Understanding these interactions enables the rational design of crystalline materials, single-component as well as multi component solids, with tailored structures and properties.4–9 Due to their directionality and predictability, HBs and XBs are among the most studied intermolecular interactions, with applications in the crystal engineering of both organic and metal–organic systems.1,4,10–14 Their strengths range from weak (∼10 kJ mol−1) to strong (>40 kJ mol−1).15,16 Halogen bonds, characterised by a localised σ-hole, are generally more directional than hydrogen bonds and can be finely tuned by varying the halogen atom or adjacent substituents.17–21 Despite extensive studies on systems dominated by either HB or XB, the interplay between them—especially in cocrystals of neutral bifunctional HB/XB donors—remains relatively underexplored.22,23 The Cambridge Structural Database (CSD)24 contains only 65 entries on multicomponent systems involving nitrogen-based acceptors and simple HB/XB bifunctional donors e.g. perhalogenated anilines, phenols, benzoic acids, and N-(benzylidene)hydroxylamines, representing the majority of studied systems featuring neutral HB/XB bifunctional donors.25–30 However, another well-established approach to studying systems containing bifunctional HB/XB donors involves salts based on halogenated aromatic amines and halogenated N-heterocycles (e.g. halopyridines).31–38 Over the past two decades, both protonated and N-alkylated halogenopyridines have been extensively investigated as halogen bond donors, forming interactions with a variety of organic and inorganic anions.10,39–49 Similar to neutral halogen bond donors, the strength of cationic halogen bond donors decreases from iodo- to chloro-substituted derivatives.32,36,49 Stilinović and co-workers have recently performed a structural and computational study of the potential of halopyridinium cations as halogen bond donors.36 They investigated iodide salts of mono-halogenated pyridine derivatives in both protonated and N-methylated forms and have shown that although protonation and N-methylation of halogenopyridines enhance the electrostatic potential (ESP) of the halogen σ-hole, this site is not always the most positive region on the cation, especially in chloropyridinium derivatives. In these cases, hydrogen and carbon atoms often exhibit higher ESP values, explaining the low frequency of halogen bonding in their crystal structures. In accord with their findings and considerations, our analysis of the CSD on crystal structures containing simple 2-, 3- and 4-halopyridinium cations has shown two general trends, firstly, that iodopyridinium cations reliably form halogen bonds regardless of the position (about 80% frequency for 2-halopyridinium cations and over 90% for 4-halopyridinium cations), while bromopyridinium and chloropyridinium cations have similar frequencies for each position of the halogen atom, and secondly, that 2- and especially 4-halopyridinium cations are significantly more frequent halogen bond donors (Table S4).24 The larger halogen size may compensate for lower ESP, facilitating stronger halogen bonding through reduced steric hindrance and increased contact surface. Thus, while halopyridinium cations are not necessarily superior to neutral donors, iodopyridinium species in particular serve as reliable bifunctional HB/XB donors and are valuable tools in the design of halogen- and hydrogen-bonded supramolecular architectures.

As a step towards further exploration of both the potential and the limitations of halogenopyridinium cations as bifunctional HB/XB donors with larger organic anions, in this research, we selected a series of mono- and dihalopyridines: 3-chloropyridine (3Clpy), 3-bromopyridine (3Brpy), 3-iodopyridine (3Ipy), 4-iodopyridine (4Ipy), 2,6-dichloropyridine (26diClpy), 2,6-dibromopyridine (26diBrpy), 3,5-dichloropyridine (35diClpy), 3,5-dibromopyridine (35diBrpy), 5-bromo-2-chloropyridine (5Br2Clpy) and 5-bromo-2-iodopyridine (5Br2Ipy) (Scheme 1) and combined them with two highly acidic sulfonic acids, benzenesulfonic (bsaH, pKa = −2.7) and p-toluenesulfonic acids (ptsaH, pKa = −5.4).50 Our hypothesis was that the combination of sulfonic acids with halopyridines would result in the protonation of the pyridyl nitrogen atom, allowing us to obtain salts featuring strong N–H⋯O hydrogen bonds. Since these acids can be multitopic acceptors of hydrogen or halogen bonds through their three oxygen atoms, we expected the simultaneous presence of X⋯O halogen bonding, which would depend on the halopyridine used. Specifically, we anticipated that bromo- and iodopyridines would form halogen bonds, while chloropyridines would not, in accordance with previous studies.36,51,52 Additionally, we were interested in evaluating the effect of the position of halogen atoms both in mono- and dihalopyridines on the overall cation–anion network.


image file: d5ce00870k-s1.tif
Scheme 1 Molecular structures of sulfonic acids and mono- and dihalopyridines used in this study.

Salt screening experiments were performed by liquid-assisted grinding (LAG) and crystallisation from solutions. Bulk products of the 5Br2Ipy salts required for further characterisation were also obtained by slurrying reactant mixtures for several days in n-hexane. Mechanochemical experiments were performed on a Retsch MM200 Shaker Mill using stainless steel jars and stainless steel balls under normal laboratory conditions (temperature ca. 25 °C, 40–60% relative humidity, see the SI for details). Crystallisation experiments were performed by dissolving a reactant mixture in an appropriate solvent, with heating, followed by letting the solvent or solvent mixture cool down and evaporate at room temperature. The obtained products were characterised by powder (PXRD) and single-crystal X-ray diffraction (SCXRD), as well as by differential scanning calorimetry (DSC). Potentiometric and UV/vis spectrophotometric titrations of mono- and dihalopyridines with dilute hydrochloric acid or perchloric acid were performed in order to determine the pKa values of pyridines and to compare their Lewis basicities with the results obtained in the solid state (see the SI for titration details, experimental and calculated curves, species distribution curves and UV/vis spectra).

Out of 20 combinations, we obtained a total of 10 novel solids by crystallisation experiments from a solution of reactants, which were all characterised by SCXRD and found out to be salts. Of those, eight were obtained by LAG (Table 1). Milling 3Clpy and ptsaH, 3Brpy and ptsaH, or 35diBrpy and ptsaH under the same conditions resulted in liquid products. Slurry experiments were used to obtain bulk amounts of pure (bsa)(5Br2IpyH) and (ptsa)(5Br2IpyH) products.

Table 1 Comparison of results obtained mechanochemically (LAG) and by crystallisation experiments in solution (SOL)
Halopyridine bsaH ptsaH
LAG SOL LAG SOL
3Clpy + + +
3Brpy + + +
3Ipy + + + +
4Ipy + + + +
35diClpy +
35diBrpy +
26diClpy
26diBrpy
5Br2Clpy
5Br2Ipy + + + +


5Br2Ipy was found to be the only dihalopyridine which formed salts when reacted with both acids. The solids obtained by LAG from the systems containing 2,6- or 3,5-dihalopyridine and bsaH and ptsaH were revealed to be either solid mixtures of the reactants or a mixture of an unknown phase and one of the reactants. Products obtained by milling 35diClpy and bsaH, or 35diBrpy and bsaH could not be fully characterised since solution experiments resulted in mixtures or amorphous phases. In order to rationalise the results of our salt screening, we investigated the protonation properties of the studied pyridine derivatives in aqueous solutions. It is important to emphasise that the aqueous pKa values have been commonly used to interpret the reactivity of solids in the solid state that potentially involve proton transfer or to rationalise the outcomes of salt or cocrystal screening either mechanochemically or via solution crystallisation from a variety of non-aqueous solvents.53–55 Therefore, the measured pKa values should be interpreted as a measure of the relative intrinsic basicity of the studied pyridine derivatives and should not be correlated with proton transfer mechanisms under the used LAG conditions (where the liquid phase has a catalytic role, can influence the molecular diffusion, the crystallinity of the product, etc.)56–58 and crystallisation conditions.55 We performed pH potentiometric titrations (see the SI for experimental details) which enabled the determination of pKa values for 3Clpy, 3Brpy, 3Ipy, and 4Ipy (Table 2). On the other hand, the presence of 26diClpy, 26diBrpy, 35diClpy, 35diBrpy or 5Br2Clpy in the titrated solution had no evident effect on the pH which suggested that these compounds featured rather low basicity. Therefore, we performed spectrophotometric titrations, which is a method suitable for the determination of such low pKa values given that the characteristic spectra of the protonation species differ significantly. Indeed, as excess of acid was added to the solutions of investigated pyridines, significant spectral changes were detected and the obtained titration curves could be processed by assuming protonation of the pyridine molecule. This approach enabled quantitative characterisation of protonation properties for 35diClpy and 35diBrpy and yielded pKa values lower than 1, confirming that the basicity of these compounds is rather low (Table 2). Furthermore, when 26diClpy and 26diBrpy were titrated with perchloric acid, no spectral changes occurred, even after more than 5000 molar equivalents of acid were added. This strongly suggested that the protonation of the 2,6-substitued derivatives is an extremely unfavorable process.

Table 2 Experimentally determined pKa values for mono- and dihalopyridines used in this study. Both potentiometric and spectrophotometric determinations were performed in water, at an ionic strength of 0.1 mol dm−3 and at 25 °C
Halopyridine pKa
a Potentiometric value. b Spectrophotometric value.
3Clpy 3.02(1)a
3Brpy 3.17(1);a 2.91(1)b
3Ipy 3.55(1)a
4Ipy 4.04(1)a
35diClpy 0.37(1)b
35diBrpy 0.75(1)b


A comparison of the results obtained by the two methods for 3Brpy shows that they give similar values; therefore, the spectrophotometric values can be used in conjunction with potentiometric ones for the purpose of establishing a trend. It should be mentioned that the pKa value for 5Br2Ipy could not be determined, because of too low solubility of the compound. The results described above provide a strong foundation for the rationalisation of the fact that salts of 2,6- and 3,5-dihalopyridines could not be obtained. Namely, our results strongly indicate that these pyridines simply feature too low a basicity for proton transfer from the studied organic acids to be thermodynamically favorable in any medium, including in the solid state. Surprisingly, it seems that the basicity is so low that not even hydrogen bonded cocrystals could be formed.

Structural analysis of the obtained salts revealed that the expected charge-assisted N–H⋯O hydrogen bonds are formed in all ten cases. Additionally, X⋯O halogen bonds (X = I, Br, Cl) are present in the structure of the salts with bromo- and iodo-substitued pyridines and in (3ClpyH)(bsa). On the other hand, Cl⋯O halogen bonds have been found in (3ClpyH)(ptsa), a trend that is in line with previous studies affirming the chlorine atom as the weakest halogen bond donor. Hydrogen bonds N–H⋯O and all halogen bonds and their corresponding parameters are listed in Table 3. A characteristic typical for the 3-chloropyridinium and 3-bromopyridinium salts is the formation of a tetrameric cation–anion structural motif. In (3ClpyH)(ptsa), the tetramer is formed by a combination of N–H⋯O and C–H⋯O hydrogen bonds (Fig. 1a), and tetramers are then connected into a 3D network by a combination of C–H⋯Cl, C–H⋯π and additional C–H⋯O contacts. The tetramer motif in (3ClpyH)(bsa), (3BrpyH)(bsa) and (3BrpyH)(ptsa) is formed by a combination of N–H⋯O and Br⋯O or Cl⋯O bonding (Fig. 1b–d). In these bsa salts, one oxygen atom is a simultaneous hydrogen and halogen bond acceptor, while in the ptsa salt the tetramer is established through two different oxygen atoms. In (3ClpyH)(bsa) and (3BrpyH)(bsa), these tetramers are further connected first into a chain by bifurcated C–H⋯O hydrogen bonds and then into a 3D network by a combination of additional C–H⋯O and C–H⋯π hydrogen bonds, while in (3BrpyH)(ptsa) these tetrameric units connect into a 3D network by additional C–H⋯O hydrogen bonds. The tetramer motif is also present in (3IpyH)(ptsa), where it is formed by a combination of N–H⋯O and I⋯O bonding, and where the iodine atom is a bifurcated donor (Fig. 2b). The connectivity yielding the 3D network is achieved through a combination of C–H⋯O and C–H⋯I hydrogen bonds and stacking. In (3IpyH)(bsa), N–H⋯O and I⋯O halogen bonds lead to the formation of an undulating chain that is further stabilised by C–H⋯O hydrogen bonds (Fig. 2a). The chains are connected into a 3D network through additional C–H⋯O hydrogen bonds. As we hypothesised, a change in the position of the iodine substituent on the pyridine ring leads to a significantly different network.

Table 3 Geometric parameters of N–H⋯O hydrogen and halogen bonds in the obtained salts
Salt d(N–H⋯O)/Å Angle/° X⋯A d(X⋯A)/Å Angle/° R.S.a/%
a R.S. = 1 – d(D⋯A)/[rvdW(D) + rvdW(A)]; rvdW are Alvarez's van der Waals radii.59
(3ClpyH)(bsa) 2.776 171.3 Cl1⋯O1 3.308 152.8 0.3
(3ClpyH)(ptsa) 2.750 172.6
(3BrpyH)(bsa) 2.918 167.9 Br1⋯O3 3.136 158.5 6.6
(3BrpyH)(ptsa) 2.598 163.9 Br1⋯O2 3.284 163.6 2.3
(3IpyH)(bsa) 2.699 159.9 I1⋯O3 2.973 173.1 16.0
(3IpyH)(ptsa) 2.629 162.5 I1⋯O3 3.253 164.7 8.1
I1⋯O2 3.464 163.5 2.1
(4IpyH)(bsa) 2.684 171.6 I1⋯O3 2.998 171.4 15.3
(4IpyH)(ptsa) 2.670 175.3 I1⋯O2 2.951 173.9 16.6
(5Br2IpyH)(bsa) 2.662 175.5 I1⋯O3 2.835 171.8 19.9
2.871 157.3 I2⋯O2 3.059 171.7 13.6
Br2⋯O2 3.074 153.7 8.5
(5Br2IpyH)(ptsa) 2.709 176.9 I1⋯O1 2.798 170.8 21.0



image file: d5ce00870k-f1.tif
Fig. 1 Halogen and hydrogen bonded tetramers in crystal structures of: a) (3ClpyH)(ptsa), b) (3ClpyH)(bsa), c) (3BrpyH)(bsa) and d) (3BrpyH)(ptsa).

image file: d5ce00870k-f2.tif
Fig. 2 Parts of supramolecular chains in crystal structures of: a) (3IpyH)(bsa), b) (3IpyH)(ptsa), c) (4IpyH)(bsa), and d) (4IpyH)(ptsa).

In (4IpyH)(bsa), chains in the crystal structure are formed by I⋯O halogen bonds in cooperation with N–H⋯O and C–H⋯O hydrogen bonds that form a R22(7) motif. Two parallel chains are then connected into a wider chain by additional C–H⋯O hydrogen bonds; these resultant chains are connected into layers by C–H⋯π contacts, and the layers are then stacked in the 3D structure. On the other hand, in (4IpyH)(ptsa), chains are formed by a combination of N–H⋯O hydrogen and I⋯O halogen bonds (Fig. 2c and d), and the ptsa anions alternate between two orientations. The chains in (4IpyH)(ptsa) are further connected into 2D layers by C–H⋯O hydrogen bonds. As already stated, only two salts including dihalopyridines have been obtained, both involving 5Br2IpyH. The main similarity between the structures of (5Br2IpyH)(ptsa) and (5Br2IpyH)(bsa) lies in the fact that a combination of I⋯O and strong N–H⋯O bonds leads to the formation of a zipper-like chain (Fig. 3a). In the ptsa salt, the chains are then connected into a 3D network by numerous C–H⋯O hydrogen bonds. In (5Br2IpyH)(bsa), two symmetrically inequivalent bsa and 5Br2IpyH ions are present. While one ion pair forms the aforementioned chain, the other cation and anion are statistically disordered (see the SI for details), also forming a chain held together by N–H⋯O and C–H⋯O hydrogen bonds.


image file: d5ce00870k-f3.tif
Fig. 3 Parts of supramolecular chains in crystal structures of: a) (5Br2IpyH)(ptsa) and b) (5Br2IpyH)(bsa). Disordered formula units in b) are omitted for clarity.

This chain is linked to nearby zipper-like chains via I⋯O and Br⋯O halogen bonds (Fig. 3b). The final 3D network is obtained by combining all of the mentioned interactions with additional C–H⋯O hydrogen bonds.

Thermal analysis results show that in most cases there is a single, well-defined peak corresponding to the melting point in the temperature range of 111–157 °C (Table 4). Three trends can be identified: 1) salt melting or decomposition temperatures are well above the melting temperatures of both the sulfonic acid and the used halopyridine; 2) salts with bsa have higher melting or decomposition temperatures than corresponding ptsa salts, an exception being 5Br2IpyH salts, where the opposite is the case; 3) exchanging a halogen atom for another that is a stronger halogen bond donor results in a slight increase in the melting or decomposition temperature (the only exception is (3ClpyH)(bsa)).

Table 4 Onset temperatures (te) of melting and decomposition processes in salt DSC curves, and tabulated values for sulfonic acids and halopyridines that are solids at 25 °C
Compound t e/°C
a Decomposition temperature. b Tabulated value.
(3ClpyH)(bsa) 138
(3ClpyH)(ptsa) 111
(3BrpyH)(bsa) 130
(3BrpyH)(ptsa) 110
(3IpyH)(bsa) 135
(3IpyH)(ptsa) 125
(4IpyH)(bsa) 136a
(4IpyH)(ptsa) 115a
(5Br2IpyH)(bsa) 138
(5Br2IpyH)(ptsa) 156
bsaH 51b
ptsaH 38b
3Ipy 53–56b
4Ipy 80b
5Br2Ipy 112–113b


Conclusions

To conclude, we have successfully synthesised ten salts of benzenesulfonic and p-toluenesulfonic acids with a series of mono- and dihalopyridines. In accord with previous findings and our hypothesis, the obtained structural data allow us to ascertain that the dominant intermolecular interactions in these systems are charge-assisted hydrogen bonds formed upon proton transfer from the acid to the pyridine nitrogen atom. The next most important interactions are the X⋯O halogen bonds, of which I⋯O are expectedly stronger (according to the geometric parameters) than Br⋯O and Cl⋯O halogen bonds. Monohalopyridines have been determined to be more reliable as hydrogen bond donors. According to our results, this is due to their higher basicity compared to dihalopyridines, combined with the observed lack of Cl⋯O halogen bonding and relative weakness of Br⋯O halogen bonding. Therefore, bromo- and iodopyridines have been confirmed as potential bifunctional donor molecules in systems involving strong organic acids. With regards to bsaH and ptsaH, both acids have proven amenable coformers for halopyridines of high enough basicity, as the resulting bsa and ptsa ions were shown to be polytopic hydrogen and halogen bond acceptors that could participate in the formation of a variety of supramolecular architectures.

Author contributions

Investigation: MČ performed the synthesis of salts and the crystallisation experiments. Conceptualisation: VN, NB and DC conceived and designed the study and formulated research aims. Formal analysis: VN performed single-crystal X-ray diffraction measurements, thermal analysis and the associated data processing. MČ and NB performed the determination of pKa values. Supervision: the study was supervised by VN and DC. Visualisation: VN and DC prepared the schemes and figures. Writing: the manuscript draft was written by VN with contributions from all authors. Reviews and editing were done by VN and DC. DC ensured funding acquisition and project management.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article (experimental procedures, DSC curves, PXRD patterns, crystal data and ORTEP representations of obtained structures, potentiometric and spectrophotometric data) have been included as part of the supplementary information (SI). Supplementary information is available. See DOI: https://doi.org/10.1039/d5ce00870k.

CCDC 2484628–2484637 contain the supplementary crystallographic data for this paper.60a–j

Acknowledgements

This research was funded by the Croatian Science Foundation under the research project IP-2019-04-1868. Additionally, we acknowledge support of the project CIuK cofinanced through the European Regional Development Fund-Competitiveness and Cohesion Operational Programme (Grant KK.01.1.1.02.0016). The authors are very grateful to Marina Ratkaj for helping with SCXRD data collection.

Notes and references

  1. G. R. Desiraju, J. Am. Chem. Soc., 2013, 135, 9952–9967 CrossRef CAS PubMed.
  2. G. R. Desiraju, Angew. Chem., Int. Ed., 2007, 46, 8342–8356 CrossRef CAS PubMed.
  3. C. B. Aakeröy, S. V. Panikkattu, B. DeHaven and J. Desper, Cryst. Growth Des., 2012, 12, 2579–2587 CrossRef.
  4. G. Cavallo, P. Metrangolo, R. Milani, T. Pilati, A. Priimagi, G. Resnati and G. Terraneo, Chem. Rev., 2016, 116, 2478–2601 CrossRef CAS PubMed.
  5. K. M. Hutchins, R. Soc. Open Sci., 2018, 5, 180564 CrossRef PubMed.
  6. J.-C. Christopherson, F. Topić, C. J. Barrett and T. Friščić, Cryst. Growth Des., 2018, 18, 1245–1259 CrossRef CAS.
  7. K. T. Mahmudov, M. N. Kopylovich, M. F. C. Guedes da Silva and A. J. L. Pombeiro, Coord. Chem. Rev., 2017, 345, 54–72 CrossRef CAS.
  8. A. Mukherjee, S. Tothadi and G. R. Desiraju, Acc. Chem. Res., 2014, 47, 2514–2524 CrossRef CAS PubMed.
  9. D. Yan, D.-K. Bučar, A. Delori, B. Patel, G. O. Lloyd, W. Jones and X. Duan, Chem. – Eur. J., 2013, 19, 8213–8219 CrossRef CAS PubMed.
  10. R. Bertani, P. Sgarbossa, A. Venzo, F. Lelj, M. Amati, G. Resnati, T. Pilati, P. Metrangolo and G. Terraneo, Coord. Chem. Rev., 2010, 254, 677–695 CrossRef CAS.
  11. T. Steiner, Angew. Chem., Int. Ed., 2002, 41, 48–76 CrossRef CAS.
  12. V. Nemec, K. Lisac, N. Bedeković, L. Fotović, V. Stilinović and D. Cinčić, CrystEngComm, 2021, 23, 3063–3083 RSC.
  13. M. K. Corpinot and D.-K. Bučar, Cryst. Growth Des., 2019, 19, 1426–1453 CrossRef CAS.
  14. A. Mukherjee, S. Tothadi and G. R. Desiraju, Acc. Chem. Res., 2014, 47, 2514–2524 CrossRef CAS PubMed.
  15. K. Wendler, J. Thar, S. Zahn and B. Kirchner, J. Phys. Chem. A, 2010, 114, 9529–9536 CrossRef CAS PubMed.
  16. P. J. Costa, Phys. Sci. Rev., 2017, 2, 20170136 Search PubMed.
  17. V. Stilinović, G. Horvat, T. Hrenar, V. Nemec and D. Cinčić, Chem. – Eur. J., 2017, 23, 5244–5257 CrossRef PubMed.
  18. D. Cinčić, T. Friščić and W. Jones, Chem. – Eur. J., 2008, 14, 747–753 CrossRef.
  19. M. Kolář, J. Hostaš and P. Hobza, Phys. Chem. Chem. Phys., 2014, 16, 9987–9996 RSC.
  20. C. Präsang, A. C. Whitwood and D. W. Bruce, Cryst. Growth Des., 2009, 9, 5319–5326 CrossRef.
  21. P. Metrangolo, F. Meyer, T. Pilati, G. Resnati and G. Terraneo, Angew. Chem., Int. Ed., 2008, 47, 6114–6127 CrossRef CAS PubMed.
  22. C. C. Robertson, J. S. Wright, E. J. Carrington, R. N. Perutz, C. A. Hunter and L. Brammer, Chem. Sci., 2017, 8, 5392–5398 RSC.
  23. C. B. Aakeröy, P. D. Chopade and J. Desper, Cryst. Growth Des., 2011, 11, 5333–5336 CrossRef.
  24. C. R. Groom, I. J. Bruno, M. P. Lightfoot and S. C. Ward, Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater., 2016, 72, 171–179 CrossRef CAS PubMed.
  25. C. B. Aakeröy, M. Fasulo, N. Schultheiss, J. Desper and C. Moore, J. Am. Chem. Soc., 2007, 129, 13772–13773 CrossRef PubMed.
  26. C. B. Aakeröy, S. Panikkattu, P. Chopade and J. Desper, CrystEngComm, 2013, 15, 3125–3136 RSC.
  27. C. B. Aakeröy, N. Schultheiss, A. Rajbanshi, J. Desper and C. Moore, Cryst. Growth Des., 2009, 9, 432–441 CrossRef PubMed.
  28. M. D. Perera, J. Desper, A. S. Sinha and C. B. Aakeröy, CrystEngComm, 2016, 18, 8631–8636 RSC.
  29. C. B. Aakeröy, C. L. Spartz, S. Dembowski, S. Dwyre and J. Desper, IUCrJ, 2015, 2, 498–510 CrossRef PubMed.
  30. N. Baus Topić, S. G. Dash, E. Topić, M. Arhangelskis and D. Cinčić, Cryst. Growth Des., 2024, 24, 5078–5088 CrossRef PubMed.
  31. M. Oszajca, L. Smrčok, H. Pálková and W. Łasocha, J. Mol. Struct., 2012, 1021, 70–75 CrossRef CAS.
  32. K. Raatikainen, M. Cametti and K. Rissanen, Beilstein J. Org. Chem., 2010, 6, 1 Search PubMed.
  33. R. J. Attrell, C. M. Widdifield, I. Korobkov and D. L. Bryce, Cryst. Growth Des., 2012, 12, 1641–1653 CrossRef CAS.
  34. K. Kubo, K. Takahashi, S. Nakagawa, K. I. Sakai, S. I. Noro, T. Akutagawa and T. Nakamura, Cryst. Growth Des., 2021, 21, 2340–2347 CrossRef CAS.
  35. L. Fotović and V. Stilinović, CrystEngComm, 2020, 22, 4039–4046 RSC.
  36. L. Fotović, N. Bedeković and V. Stilinović, Cryst. Growth Des., 2021, 21, 6889–6901 CrossRef PubMed.
  37. F. Zordan, S. L. Purver, H. Adams and L. Brammer, CrystEngComm, 2005, 7, 350–354 RSC.
  38. N. Jakupec, L. Fotović and V. Stilinović, CrystEngComm, 2020, 22, 8142–8150 RSC.
  39. L. H. Thomas, M. S. Adam, A. O'Neill and C. C. Wilson, Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 2013, 69, 1279–1288 CrossRef CAS PubMed.
  40. F. F. Awwadi, R. D. Willett, K. A. Peterson and B. Twamley, J. Phys. Chem. A, 2007, 111, 2319–2328 CrossRef CAS PubMed.
  41. M. Freytag, P. G. Jones, B. Ahrens and A. K. Fischer, New J. Chem., 1999, 23, 1137–1139 RSC.
  42. G. Mínguez Espallargas, F. Zordan, L. Arroyo Marin, H. Adams, K. Shankland, J. van de Streek and L. Brammer, Chem. – Eur. J., 2009, 15, 7554–7568 CrossRef PubMed.
  43. L. Brammer, G. Mínguez Espallargas and H. Adams, CrystEngComm, 2003, 5, 343–345 RSC.
  44. G. Mínguez Espallargas, L. Brammer and P. Sherwood, Angew. Chem., Int. Ed., 2006, 45, 435–440 CrossRef PubMed.
  45. S. Derossi, L. Brammer, C. A. Hunter and M. D. Ward, Inorg. Chem., 2009, 48, 1666–1677 CrossRef CAS PubMed.
  46. L. Fotović and V. Stilinović, Crystals, 2021, 11, 1240 CrossRef.
  47. J. E. Ormond Prout, P. Smart and L. Brammer, Cryst. Growth Des., 2012, 12, 205–216 CrossRef CAS.
  48. V. Amendola, G. Bergamaschi, M. Boiocchi, N. Fusco, M. V. La Rocca, L. Linati, E. Lo Presti, M. Mella, P. Metrangolo and A. Miljkovic, RSC Adv., 2016, 6, 67540–67549 RSC.
  49. L. Fotović, N. Bedeković and V. Stilinović, Cryst. Growth Des., 2022, 22, 1333–1344 CrossRef PubMed.
  50. J. P. Guthrie, Can. J. Chem., 1978, 56, 2342–2354 CrossRef CAS.
  51. L. Fotović, N. Bedeković, K. Pičuljan and V. Stilinović, Cryst. Growth Des., 2022, 22, 7508–7517 CrossRef.
  52. L. Posavec, V. Nemec, V. Stilinović and D. Cinčić, Cryst. Growth Des., 2021, 21, 6044–6050 CrossRef CAS PubMed.
  53. A. J. Cruz-Cabeza, CrystEngComm, 2012, 14, 6362–6365 RSC.
  54. V. Stilinović and B. Kaitner, Cryst. Growth Des., 2012, 12, 5763–5772 CrossRef.
  55. S. L. Childs, G. P. Stahly and A. Park, Mol. Pharmaceutics, 2007, 4, 323–338 CrossRef CAS PubMed.
  56. D. Braga, S. L. Giaffreda, K. Rubini, F. Grepioni, M. R. Chierotti and R. Gobetto, CrystEngComm, 2007, 9, 39–45 RSC.
  57. T. Friščić, S. L. Childs, S. A. A. Rizvi and W. Jones, CrystEngComm, 2009, 11, 418–426 RSC.
  58. T. Friščić and W. Jones, Cryst. Growth Des., 2009, 9, 1621–1637 CrossRef.
  59. S. Álvarez, Dalton Trans., 2013, 42, 8617–8636 RSC.
  60. (a) CCDC 2484628: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdg9w; (b) CCDC 2484629: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgbx; (c) CCDC 2484630: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgcy; (d) CCDC 2484631: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgdz; (e) CCDC 2484632: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgf0; (f) CCDC 2484633: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgg1; (g) CCDC 2484634: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgh2; (h) CCDC 2484635: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgj3; (i) CCDC 2484636: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgk4; (j) CCDC 2484637: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pdgl5.

Footnote

Dedicated to Professor Resnati, celebrating a career in fluorine and noncovalent chemistry on the occasion of his 70th birthday.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.